公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2004 | Comparison of HPV DNA vaccines employing intracellular targeting strategies | Kim J.W.; Hung C.-F.; Juang J.; He T.; Kim T.W.; Armstrong D.K.; Pai S.I.; PEI-JER CHEN ; Lin C.-T.; Boyd D.A.; Wu T.-C. | Gene Therapy | 106 | 91 | |
1993 | Comparison of Three Different Immunoassays and PCR for the Detection of Hepatitis C Virus Infection in Pregnant Women in Taiwan | HO-HSIUNG LIN ; JIA-HORNG KAO ; Leu J. H.; Young Y. C.; Lee T. Y.; PEI-JER CHEN ; DING-SHINN CHEN | Vox Sanguinis | 11 | 10 | |
1999 | Comparison of two methods for quantification of hepatitis B viral DNA | JIA-HORNG KAO ; Wood M.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 13 | 12 | |
2020 | Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver | Ho T.-C.; Wang E.-Y.; KUN-HUEI YEH ; YUNG-MING JENG ; Horng J.-H.; Wu L.-L.; Chen Y.-T.; Huang H.-C.; CHIA-LANG HSU ; PEI-JER CHEN ; Shiou-Hwei Yeh ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 10 | 9 | |
2003 | Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors | Tai K.-F.; PEI-JER CHEN ; Chen D.-S.; Hwang L.-H. | Journal of Gene Medicine | 27 | 22 | |
2013 | Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC) | Park J.-W.; Amarapurkar D.; Chao Y.; PEI-JER CHEN ; Geschwind J.-F.H.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; ANN-LII CHENG | Liver International | 69 | 60 | |
2001 | The conserved serine 177 in the delta antigen of hepatitis delta virus is one putative phosphorylation site and is required for efficient viral RNA replication | Mu J.-J.; Chen D.-S.; PEI-JER CHEN | Journal of Virology | 33 | 30 | |
1990 | Continuous expression and replication of the hepatitis δ virus genome in Hep G2 hepatoblastoma cells transfected wth cloned viral DNA | PEI-JER CHEN ; YEN-PING KUO ; Chen M.-L.; Tu S.-J.; Chiu M.-N.; Wu H.-L.; Hsu H.-C.; Chen D.-S. | Proceedings of the National Academy of Sciences of the United States of America | 28 | 26 | |
2022 | Contrasting Patterns in the Early Stage of SARS-CoV-2 Evolution between Humans and Minks | Tai, Jui-Hung; Sun, Hsiao-Yu; Tseng, Yi-Cheng; Li, Guanghao; SUI-YUAN CHANG ; Shiou-Hwei Yeh ; PEI-JER CHEN ; Chaw, Shu-Miaw; HURNG-YI WANG | MOLECULAR BIOLOGY AND EVOLUTION | 2 | 2 | |
2015 | Contribution of adiponectin and its type 1 receptor to age-related hearing impairment | Chen-Chi Wu ; Tsai C.-H.; Lu Y.-C.; Lin H.-C.; Hwang J.-H.; Lin Y.-H.; WEI-SHIUNG YANG ; PEI-JER CHEN ; WEI-CHIH LIAO ; Lee Y.L.; TIEN-CHEN LIU ; Hsu C.-J. | Neurobiology of Aging | 14 | 13 | |
1992 | Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV. | HO-HSIUNG LIN ; HONG-YUAN HSU ; MEI-HWEI CHANG ; Wang, Jin-Town ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 5 | 0 | |
2006 | Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan | LI-HUI TSENG ; Lin M.-T.; Shau W.-Y.; Lin W.-C.; Chang F.-Y.; KUO-LIONG CHIEN ; Hansen J.A.; Chen D.-S.; PEI-JER CHEN | Tissue Antigens | 53 | 43 | |
2018 | Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023)) | Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN ; Kim I.; Shiau C.-W. | European Journal of Medicinal Chemistry | 1 | 1 | |
2017 | Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047)) | Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F. | Journal of Hepatology | 1 | 1 | |
2017 | Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007)) | Tai W.-T.; ANN-LII CHENG ; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN ; Chen K.-F. | Journal of Hepatology | 0 | 1 | |
2007 | Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan | Sullivan S.D.; Veenstra D.L.; PEI-JER CHEN ; Chang T.-T.; Chuang W.-L.; Tsai C.; Patel K. | Journal of Gastroenterology and Hepatology (Australia) | 24 | 22 | |
2020 | Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection | Tsou H.-H.; HUNG-CHIH YANG ; Hsiao C.-F; Hsiung C.A; Liu T.-W; Chuang M.-H; Wu H.-Y; Hsu Y.-T; Tsui C.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology Group | Journal of the Formosan Medical Association | 8 | 8 | |
2014 | The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo | Lin S.-R.; HUNG-CHIH YANG ; Kuo Y.-T; CHUN-JEN LIU ; Yang T.-Y; Sung K.-C; Lin Y.-Y; HURNG-YI WANG ; Wang C.-C; Shen Y.-C; Wu F.-Y; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN | Molecular Therapy - Nucleic Acids | 325 | 301 | |
1993 | Cytogenetic studies on human liver cancer cell lines | Chen H.-L.; Chiu T.-S.; PEI-JER CHEN ; Chen D.-S. | Cancer Genetics and Cytogenetics | 21 | 20 | |
2021 | D614g substitution of sars-cov-2 spike protein increases syncytium formation and virus titer via enhanced furin-mediated spike cleavage | Cheng, Ya Wen; TAI-LING CHAO ; Li, Chiao Ling; Wang, Sheng Han; Kao, Han Chieh; Tsai, Ya Min; HURNG-YI WANG ; Hsieh, Chi Ling; Lin, You Yu; PEI-JER CHEN ; SUI-YUAN CHANG ; Shiou-Hwei Yeh | mBio | 21 | 18 | |